chr16-21697781-CTGCTT-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_144672.4(OTOA):c.746_751delinsA(p.Ser249TyrfsTer21) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
OTOA
NM_144672.4 frameshift
NM_144672.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.79
Genes affected
OTOA (HGNC:16378): (otoancorin) The protein encoded by this gene is specifically expressed in the inner ear, and is located at the interface between the apical surface of the inner ear sensory epithelia and their overlying acellular gels. It is prposed that this protein is involved in the attachment of the inner ear acellular gels to the apical surface of the underlying nonsensory cells. Mutations in this gene are associated with autosomal recessive deafness type 22 (DFNB22). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-21697781-CTGCTT-A is Pathogenic according to our data. Variant chr16-21697781-CTGCTT-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 228383.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOA | NM_144672.4 | c.746_751delinsA | p.Ser249TyrfsTer21 | frameshift_variant | 10/29 | ENST00000646100.2 | NP_653273.3 | |
OTOA | NM_001161683.2 | c.509_514delinsA | p.Ser170TyrfsTer21 | frameshift_variant | 5/24 | NP_001155155.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOA | ENST00000646100.2 | c.746_751delinsA | p.Ser249TyrfsTer21 | frameshift_variant | 10/29 | NM_144672.4 | ENSP00000496564 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2023 | Frameshift variant predicted to result in protein truncation [or nonsense mediated decay] in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 01, 2015 | The p.Ser249fs variant in OTOA has not been previously reported in individuals w ith hearing loss. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 249 and leads to a prema ture termination codon 21 amino acids downstream. This alteration is then predic ted to lead to a truncated or absent protein. Loss of function of the OTOA gene is an established disease mechanism in autosomal recessive sensorineural hearing loss. In summary, this variant meets our criteria to be classified as pathogeni c for hearing loss in an autosomal recessive manner (www.partners.org/personaliz edmedicine/lmm), based on the predicted impact of the variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at